CG Life, a leading life science and tech agency, has increased its communication capabilities for biopharma and medical industry clients through the acquisition of a well-respected New York PR agency. The acquisition further establishes CG Life’s position in providing holistic and comprehensive communication services to clients from the biopharma and medical industry. The move demonstrates CG Life’s commitment to staying abreast of industry trends and adapting to the unique needs of its clients.
The newly acquired agency offers over two decades of healthcare communication experience and a plethora of PR services. These range from traditional and sponsored media, social media planning, content creation to crisis management. The experienced team offers tailored strategies, focusing on delivering impactful messaging that resonates with audiences and enhances client visibility in the competitive healthcare field.
David Ormesher, CG Life’s CEO, stressed the importance of marketing and communication agencies needs to stay relevant, and this acquisition places CG Life at the life science innovation sector’s heart. Through this union, CG Life will be better equipped to access the life science innovation sector, thereby becoming a significant player in the industry.
This acquisition marks CG Life’s second within a month, showcasing its drive to establish a comprehensive life sciences communication platform.
CG Life strengthens communication capabilities with acquisition
The aggressive expansion strategy continued when CG Life acquired a leading biotech consulting firm in May. These strategic acquisitions extend the company’s offerings, filling the gap between life sciences and communication and reiterating the firm’s commitment to becoming a holistic resource for the life sciences industry.
Following the acquisition, all management roles of the newly incorporated company have transitioned to CG Life. Senior positions in public relations, social media, and finance areas are now held by CG Life. These changes are aimed at streamlining the workflow and introducing a fresh perspective aligned with CG Life’s vision.
The founder of the acquired firm expressed satisfaction with the merger, stating that combining their expertise with CG Life’s capabilities will bring forth excellent client services. By working with CG Life, they anticipate generating stronger impacts in the life sciences and healthcare market, navigating scientific data effectively and interpreting it for a broader audience. This merger is expected to lead to service expansion, benefiting a wide range of clients with customised solutions.
